Stomach Cancer Awareness Month

Every November reminds us of the ongoing challenge of stomach cancer, a disease that often remains unnoticed until advanced stages.
Raising awareness and promoting prevention are just as important as advancing treatment options.

Several lifestyle choices can significantly reduce the risk:
avoiding smoking and alcohol, maintaining a healthy weight, treating Helicobacter pylori infections, limiting processed or nitrate-rich foods, and including more fruits and vegetables in the daily diet.
These simple habits play a key role in lowering the global burden of stomach cancer.

At NanoAlvand, we remain committed to this mission through continuous innovation in oncology.
Our portfolio, including Fenosa®️ (Regorafenib), Tysuna®️ (Sunitinib), Xetabin®️ (Capecitabine), Alvoxal®️ (Oxaliplatin), Fiverna®️ (Fluorouracil), and Alvinotec®️ (Irinotecan Hydrochloride), supports physicians and patients in the fight against gastrointestinal and stomach malignancies.
Together, these therapies represent a comprehensive approach to targeted and cytotoxic treatment, expanding access to effective, high-quality cancer care across the region.

Together, through awareness, prevention, and innovation, we move closer to a future where early detection and better outcomes become reality.